ClinicalTrialsFinder

Mismatch Repair Deficient or MSI-High Solid Tumors Clinical Trials in Ballarat, Victoria

1 recruitingBallarat, Victoria, Australia

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Endometrial CancerAdvanced Solid TumorsMSI-H or dMMR Advanced Solid Tumors+4 more
Eikon Therapeutics160 enrolled10 locationsNCT07262619